7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Chest Computed Tomographic Image Screening for Cystic Lung Diseases in Patients with Spontaneous Pneumothorax Is Cost Effective

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rationale: Patients without a known history of lung disease presenting with a spontaneous pneumothorax are generally diagnosed as having primary spontaneous pneumothorax. However, occult diffuse cystic lung diseases such as Birt-Hogg-Dubé syndrome (BHD), lymphangioleiomyomatosis (LAM), and pulmonary Langerhans cell histiocytosis (PLCH) can also first present with a spontaneous pneumothorax, and their early identification by high-resolution computed tomographic (HRCT) chest imaging has implications for subsequent management.

          Objectives: The objective of our study was to evaluate the cost-effectiveness of HRCT chest imaging to facilitate early diagnosis of LAM, BHD, and PLCH.

          Methods: We constructed a Markov state-transition model to assess the cost-effectiveness of screening HRCT to facilitate early diagnosis of diffuse cystic lung diseases in patients presenting with an apparent primary spontaneous pneumothorax. Baseline data for prevalence of BHD, LAM, and PLCH and rates of recurrent pneumothoraces in each of these diseases were derived from the literature. Costs were extracted from 2014 Medicare data. We compared a strategy of HRCT screening followed by pleurodesis in patients with LAM, BHD, or PLCH versus conventional management with no HRCT screening.

          Measurements and Main Results: In our base case analysis, screening for the presence of BHD, LAM, or PLCH in patients presenting with a spontaneous pneumothorax was cost effective, with a marginal cost-effectiveness ratio of $1,427 per quality-adjusted life-year gained. Sensitivity analysis showed that screening HRCT remained cost effective for diffuse cystic lung diseases prevalence as low as 0.01%.

          Conclusions: HRCT image screening for BHD, LAM, and PLCH in patients with apparent primary spontaneous pneumothorax is cost effective. Clinicians should consider performing a screening HRCT in patients presenting with apparent primary spontaneous pneumothorax.

          Related collections

          Author and article information

          Journal
          Ann Am Thorac Soc
          Ann Am Thorac Soc
          AnnalsATS
          Annals of the American Thoracic Society
          American Thoracic Society
          2329-6933
          2325-6621
          January 2017
          January 2017
          : 14
          : 1
          : 17-25
          Affiliations
          [ 1 ]Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine
          [ 2 ]Department of Environmental Heath, and
          [ 3 ]Division of General Internal Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio
          Author notes
          Correspondence and requests for reprints should be addressed to Nishant Gupta, M.D., Division of Pulmonary, Critical Care, and Sleep Medicine, 231 Albert Sabin Way, MSB Room 6053, ML 0564, Cincinnati, OH 45267. E-mail: guptans@ 123456ucmail.uc.edu
          Author information
          http://orcid.org/0000-0001-9112-1315
          Article
          PMC5461992 PMC5461992 5461992 201606-459OC
          10.1513/AnnalsATS.201606-459OC
          5461992
          27737563
          e3c048ae-afb1-4b52-a5b8-c9f446056cf2
          Copyright © 2017 by the American Thoracic Society
          History
          : 13 June 2016
          : 13 October 2016
          Page count
          Figures: 4, Tables: 1, Pages: 9
          Categories
          Original Research
          Adult Pulmonary Medicine

          Birt-Hogg-Dubé syndrome,pneumothorax,pulmonary Langerhans cell histiocytosis,lymphangioleiomyomatosis

          Comments

          Comment on this article